Collins Cooper C.

Track

Insider profile

Performance

Overall performance
1.7
Performance over holding periods
1.7
30 days 90 days 120 days
Average return -24% 8.2% 15.1%
Success rate 14% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Collins Cooper C.'s trades of TherapeuticsMD Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
307.19
Quantity 25,139 -43.3%
Value US$1,666,894
Transaction date
Purchase
Price
178.39
Quantity 56,593 -13.2%
Value US$3,785,156
Transaction date
Purchase
Price
281.02
Quantity 33,178 +31.0%
Value US$1,708,933
Transaction date
Purchase
Price
1.45
Quantity 47,500 +51.4%
Value US$68,875
Transaction date
Purchase
Price
1.45
Quantity 26,500 +40.2%
Value US$38,425
Transaction date
Purchase
Price
3.33
Quantity 30,000 +83.3%
Value US$99,870
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-26 2024-08-22
B Purchase
25,139 -43.3%
307.19
US$1,666,894 		25,139 -43.3% 307.19 US$1,666,894
2024-08-23 2024-08-21
B Purchase
56,593 -13.2%
178.39
US$3,785,156 		56,593 -13.2% 178.39 US$3,785,156
2021-11-22 2021-11-18
B Purchase
33,178 +31.0%
281.02
US$1,708,933 		33,178 +31.0% 281.02 US$1,708,933
2020-06-10 2020-06-09
B Purchase
47,500 +51.4%
1.45
US$68,875 		47,500 +51.4% 1.45 US$68,875
2020-06-10 2020-06-08
B Purchase
26,500 +40.2%
1.45
US$38,425 		26,500 +40.2% 1.45 US$38,425
2019-05-15 2019-05-13
B Purchase
30,000 +83.3%
3.33
US$99,870 		30,000 +83.3% 3.33 US$99,870